September 1, 2021 - September 3, 2021

Vijaya Diagnostic IPO Basis of Allotment

VIJAYA DIAGNOSTIC CENTRE LIMITED

Our Company was incorporated as Vijaya Diagnostic Centre Private Limited on June 5, 2002 with a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on March 22, 2021 and the name of our Company was changed to Vijaya Diagnostic Centre Limited on March 26, 2021, and a fresh certificate of incorporation consequent on change of name was granted by the Registrar of Companies, Telangana at Hyderabad. For further details, see "History and Certain Corporate Matters" on page 131 of the Prospectus dated September 6, 2021, ("Prospectus").

Registered Office 3-6-16 & 17, Street No. 19. Himayatnagar, Hyderabad- 500 029, Telangana, India; Tel: +91 402342 0411;
Corporate Office:1 #6-3-883/F, Ground Floor of Family Planning Association of India, Panjagutta, Hyderabad-500082, India
Website www.vijayadiagnostic.com; Contact Person V. SriLakshmi, Company Secretary and Compliance Officer;
E-mail in@vijayadiagnostic.in
Corporate Identity Number U85195TG2002PLC039075

OUR PROMOTER: DR. S. SURENDRANATH REDDY

Our Company has filed the Prospectus dated September 6, 2021, with the Registrar of Companies, (the "Prospectus") and the Equity Shares are proposed to be listed on the National Stock Exchange of India Limited ("NSE") and the BSE Limited ("BSE") and the trading will commence on September 14, 2021.

BASIS OF ALLOTMENT

INITIAL PUBLIC OFFER OF EQUITY SHARES OF FACE VALUE OF Rs. 1 EACH ("EQUITY SHARES") OF VIJAYA DIAGNOSTIC CENTRE LIMITED ("COMPANY" OR "ISSUER") FOR CASH AT A PRICE OF Rs.531^ PER EQUITY SHARE ("OFFER PRICE"), THROUGH AN OFFER FOR SALE OF 35,688,064 EQUITY SHARES AGGREGATING TO Rs.18,942.56 MILLION ("OFFER") BY THE SELLING SHAREHOLDERS, COMPRISING OF 5,098,296 EQUITY SHARES AGGREGATING TO Rs.2,706.08 MILLION BY DR. S. SURENDRANATH REDDY ("PROMOTER SELLING SHAREHOLDER"), 29,487,290 EQUITY SHARES AGGREGATING TO Rs. 15,651.30 MILLION BY KARAKORAM LIMITED AND 1,102,478 EQUITY SHARES AGGREGATING TO Rs.585.18 MILLION BY KEDAARA CAPITAL ALTERNATIVE INVESTMENT FUND - KEDAARA CAPITAL AIF 1 ("KARAKORAM LIMITED TOGETHER WITH KEDAARA CAPITAL ALTERNATIVE INVESTMENT FUND - KEDAARA CAPITAL AIF 1 REFERRED TO AS ("INVESTOR SELLING SHAREHOLDERS") (INVESTOR SELLLING SHAREHOLDERS TOGETHER WITH THE PROMOTER SELLING SHAREHOLDER REFERRED TO AS THE ("SELLING SHAREHOLDERS"). THIS OFFER INCLUDED A RESERVATION OF 150,000 EQUITY SHARES AGGREGATING UP TO Rs. 71.85 MILLION (CONSTITUTING UP TO 0.15% OF THE POST-OFFER PAID-UP EQUITY SHARE CAPITAL) FOR PURCHASE BY ELIGIBLE EMPLOYEES (THE "EMPLOYEE RESERVATION PORTION"). THE OFFER LESS THE EMPLOYEE RESERVATION PORTION IS HEREINAFTER REFERRED TO AS THE "NET OFFER". THE OFFER AND THE NET OFFER CONSTITUTES AT LEAST 35.00% AND 34.85%, RESPECTIVELY, OF OUR POST-OFFER PAID-UP EQUITY SHARE CAPITAL.

^{^OUR COMPANY AND THE SELLING SHAREHOLDERS IN CONSULTATION WITH
THE BRLMS, OFFERED A DISCOUNT OF Rs. 52 PER EQUITY SHARE WAS OFFERED TO ELIGIBLE EMPLOYEES
BIDDING IN THE EMPLOYEE RESERVATON PORTION.

OFFER PRICE: Rs 531 PER EQUITY SHARE OF FACE VALUE
OF Rs 1 EACH

ANCHOR INVESTOR OFFER PRICE: Rs. 531 PER EQUITY
SHARE

THE OFFER PRICE IS 531 TIMES THE FACE VALUE

Risks to Investors:

1.
The 3 Book Running Lead Managers associated with the
Offer have handled 44 public issues in the past three years, out of which 15 issues closed
below the offer price on listing date.

2.
Average cost of acquisition of Equity Shares held by
the Promoter Selling Shareholder is Rs. 0.34 per Equity Share and by the Investor Selling
Shareholders is Rs. 99.49 per Equity share and Offer Price is Rs 531 per Equity Share.

3.
Weighted Average Return on Net Worth for Fiscals 2021,
2020 & 2019 is 23.14%.

4.
The Price/Earnings ratio based on basic & diluted
EPS for Fiscal 2021 for our Company at the Offer Price is 64.29, whereas the average
industry peer group Price/Earnings ratio is 90.80.

BID/ OFFER PERIOD:

OPENED ON: WEDNESDAY, SEPTEMBER 1, 2021

CLOSED ON : FRIDAY, SEPTEMBER 3, 2021

The Offer was made through the Book Building Process, in terms of Rule
19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR")
read with Regulation 31 of the SEBl ICDR Regulations and in compliance with Regulation
6(1) of the SEBI ICDR Regulations wherein not more than 50% of the Net Offer was available
for allocation on a proportionate basis to Qualified Institutional Buyers ('QIBs')
(the 'QIB Portion'). Our Company and the Selling Shareholders in consultation with
the BRLMs allocated 60% of the QIB Portion to Anchor Investors on a discretionary basis.
One-third of the Anchor Investor Portion was reserved for domestic Mutual Funds, subject
to valid Bids having been received from the domestic Mutual Funds at or above the Anchor
Investor Allocation Price. 5% of the QIB Portion (excluding the Anchor Investor Portion)
was made available for allocation on a proportionate basis to Mutual Funds only, and the
remainder of the QIB Portion was made available for allocation on a proportionate basis to
all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid
Bids having been received at or above the Offer Price. Further, not less than 15% of the
Net Offer was made available for allocation on a proportionate basis to Non-lnstitutional
Bidders and not less than 35% of the Net Offer was made available for allocation to RIBs
in accordance with the SEBI ICDR Regulations, subject to valid Bids having been received
from them at or above the Offer Price Further, Equity Shares will be allocated on a
proportionate basis to Eligible Employees applying under the Employee Reservation Portion,
subject to valid Bids received from them at or above the Offer Price. Ail potential
Bidders (except Anchor Investors) were required to mandatorily utilise the Application
Supported by Blocked Amount ('ASBA') process providing details of their respective
bank account (including UPI ID for RIBs using UPI Mechanism), in which the corresponding
Bid Amounts were blocked by the SCSBs or the Sponsor Bank, as applicable. Anchor Investors
were not permitted to participate in the Offer through the ASBA process. For details, see
"Offer Procedure" on page 272 of the Prospectus.

The bidding for Anchor Investor opened and closed on Tuesday, August
31. 2021. The company received 41 applications from 32 anchor investors for 10,873,828
Equity Shares. The Anchor investor price was finalized at Rs. 531 per Equity Share A total
of 10,661,418 Equity Shares were allocated under the Anchor Investor Portion aggregating
to 15,661,212,958.

The Offer received 244,762 applications for 117,621,644 Equity Shares
(prior to technical rejections) resulting in 3.30 times subscription. The details of the
applications received in the Offer from various categories are as under; (before technical
rejections)

Sr.
No.
Category
No.
of Applications Applied
No.
of Equity Shares
Equity
Shares Reserved as per Prospectus
No.
of times Subscribed
Amount
(Rs.)

A.
Retail
Individual Investors
243,026
9,083,228
12,438,323
0.73
4,826,040,136

B.
Non-lnstitutional
Investors
648
4,666,088
5,330,710
0.88
2,477,600,356

C.
Employee
Investors
970
146,664
150,000
0.98
70,249,928

D.
Qualified
Institutional Bidders (excluding Anchor Investors)
77
92,851,836
7,107,613
13,06
49,304,324,916

E.
Anchor
Investors
41
10,873,828
10,661,418
1.02
5,774,002,668

Total
244,762
117,621,644
35,688,064
3.30
62,452,218,004

Final Demand

A summary of the final demand as at different Bid prices is as under:

Sr.
No.
Bid
price
No.
of Equity Shares
%
to Total
Cumulative
Total
Cumulative
% of Total

1.
522
2,18,624
0.19
2,18,624
0.19

2.
523
18,704
0
02
2,37,328
0.21

3.
524
10,416
0.01
2,47,744
0.22

4.
525
81,256
0.07
3,29,000
0.29

5.
526
19,628
0.02
3,48,628
0.30

6.
527
27,552
0
02
3,76,180
0.33

7.
528
38,500
0.03
4,14,680
0.36

8.
529
29,232
0.03
4,43,912
0.39

9.
530
71,428
0.06
5,15,340
0.45

10.
531
10,25,81,612
89
59
10,30,96,952
90.04

11.
CUTOFF
1,14,07,536
9.96
11,45,04,488
100.00

TOTAL
11,45,04,488
100.00

The Basis of Allotment was finalized in consultation with the
Designated Stock Exchange, being the NSE on September 08, 2021.

A. Allotment to Retail Individual Bidders (after technical rejections)
(including ASBA Applications)

The Basis of Allotment to the Retail Individual Bidders, who have bid
at the Cut-Off Price or at the Offer Price of Rs. 531 per Equity Share, was finalized in
consultation with the NSE, This category has been subscribed to the extent of 0.70125
times. The total number of Equity Shares Allotted in Retail Portion is 8,730,680 Equity
Shares to 233,691 successful Retail Individual Bidder. The category-wise details of the
Basis of Allotment are as under:

Sr.
No.
Category
No.
of Applications Received
%
of Total
Total
No. of Equity Shares Applied
%
to Total
No.
of Equity Shares Allotted per Bidder
Ratio
Total
No. of Equity Shares Allotted

1

28
207,489
88.79
5,809,692
66.54
28
1:1
5,809,692

2.
56
14,120
6.04
790,720
9.06
56
1:1
790,720

3

84
3,758
1,61
315,672
3.62
84
1:1
315,672

4.
112
2,170
0.93
243,040
2.78
112
1:1
243,040

5.
140
1,433
0.61
200,620
2.30
140
1:1
200,620

6

168
561
0,25
97,608
1.12
168
1:1
97,608

7.
196
739
0.32
144,844
1,66
196
1:1
144,844

8.
224
249
0.11
55,776
0.64
224
1:1
55,776

9.
252
130
0.06
32,760
0.38
252
1:1
32,760

10

280
610
0.26
170,800
1.96
280
1:1
170,800

11.
308
82
0.04
25,256
0.29
308
1:1
25,256

12

336
151
0.06
50,736
0.58
336
1:1
50,736

13

364
2,179
0.93
793,156
9.08
364
1:1
793,156

TOTAL
233,691
100.00
8,730,680
100.00

8,730,680

Unsubscribed portion of 3,719,434 Equity Shares spillover to QIB
Category.

B. Allotment to Non-Institutional Bidders (After Technical Rejections)
(Sample)

The Basis of Allotment to the Non-Institutional Bidders, who have bid
at the Offer Price of Rs 531 per Equity Share or above, was finalized in consultation with
the NSE The Non-Institutional Portion has been subscribed to the extent of Rs 86769 times
The total number of Equity Shares Allotted in this category is 4,629,800 Equity Shares to
626 successful Non-Institutional Bidder The category-wise details of the Basis of
Allotment are as under:

Sr.
No.
Category
No.
of Applications Received
%
of Total
Total
No, of Equity Shares Applied
%
to Total
No,
of Equity Shares Allotted per Bidder
Ratio
Total
No, of Equity Shares Allotted

1.
392
152
24.28
59,584
1.29
392
1:1
59,584

2.
420
41
6.55
17,220
0.37
420
1:1
17,220

3.
448
3
0.48
1,344
0.03
448
1:1
1,344

4.
476
3
0.48
1,428
0.03
476
1:1
1,428

5.
504
18
2.88
9,072
0.20
504
1:1
9,072

6,
532
1
016
532
0.01
532
1:1
532

7.
560
35
5.59
19,600
0
42
560
1:1
19,600

8,
588
6
0.96
3,528
0
08
588
1:1
3,528

9.
59,080
1
0
16
59,080
1
28
59,080
1:1
59,080

10.
63,000
1
0.16
63,000
1.36
63,000
1:1
63,000

11.
79,996
1
0.16
79,996
1.73
79,996
1:1
79,996

12.
80,024
1
0.16
80,024
1.73
80,024
1:1
80,024

13.
94,080
1
0.16
94,080
2.03
94,080
1:1
94,080

14.
100,800
3
0.48
3,02,400
6.53
100,800
1:1
3,02,400

15.
188,300
1
0.16
1,88,300
4.07
188,300
1:1
1,88,300

16.
282,464
2
0.32
5,64,928
12.20
28,464
1:1
5,64,928

17

375,200
1
0.16
3,75,200
8
10
375,200
1:1
3,75,200

Unsubscribed portion of 705.964 Equity Shares spilled over to QIB category.

C. Allotment to Employee Bidders {After Technical Rejections)

The Basis of Allotment to the Employee Bidders, who have bid at the
Offer Price of Rs 479 per Equity Share or above, was finalized in consultation with the
NSE. The Employee Portion has been subscribed to the extent of Rs.77541 times. The total
number of Equity Shares Allotted in this category is 116,312 Equity Shares to 296
successful Employee Bidders. The category-wise details of the Basis of Allotment are
asunder:

Sr.
No.
Category
No,
of Applications Received
%
of Total
Total
No. of Equity Shares Applied
%
to Total
No.
of Equity Shares Allotted per Bidder
Ratio
Total
No. of Equity Shares Allotted

1,
28
49
16.55
1,372
1.18
28
1:1
1,372

2.
56
35
11.82
1,960
1.69
56
1:1
1,960

3.
84
12
4.05
1,008
0.87
84
1:1
1,008

4.
112
17
5.74
1,904
1.64
112
1:1
1,904

5.
140
12
4.05
1,680
1.44
140
1:1
1,680

6.
168
6
2.03
1,008
0.87
168
1:1
1,008

7.
196
18
6.08
3,528
3.03
196
1:1
3,528

8.
224
14
4.73
3,136
2.70
224
1:1
3,136

9.
252
3
1.01
756
0.65
252
1:1
756

10.
280
5
1.69
1,400
1.20
280
1:1
1,400

11.
308
6
2.03
1,848
1.59
308
1:1
1,848

12.
336
4
1.35
1,344
1.16
336
1:1
1,344

13.
364
3
1.01
1,092
0
94
364
1:1
1,092

14.
392
3
1.01
1,176
1.01
392
1:1
1,176

15.
420
12
4.05
5,040
4.33
420
1:1
5,040

16.
448
1
0.34
448
0.39
448
1:1
448

17.
476
1
0.34
476
0.41
476
1:1
476

18.
504
2
0.68
1,008
0.87
504
1:1
1,008

19.
532
3
1.01
1,596
1.37
532
1:1
1,596

20.
560
1
0.34
560
0.48
560
1:1
560

21.
588
1
0.34
588
0.51
588
1:1
588

22.
616
4
1.35
2,464
2.12
616
1:1
2,464

23.
644
3
1.01
1,932
1.66
644
1:1
1,932

24.
672
1
0.34
672
058
672
1:1
672

25.
700
1
0.34
700
0.60
700
1:1
700

26.
728
4
1.35
2,912
2.50
728
1:1
2,912

27.
756
1
0.34
756
0.65
756
1:1
756

28.
784
1
0.34
784
0.67
784
1:1
784

29.
812
2
0.68
1,624
1.40
812
1:1
1,624

30.
840
4
1.35
3,360
2.89
840
1:1
3,360

31.
868
2
0.68
1,736
1.49
868
1:1
1,736

32.
896
2
0.68
1,792
1.54
896
1:1
1,792

33.
924
3
1.01
2,772
2
38
924
1:1
2,772

34.
952
2
0.68
1,904
1
64
952
1:1
1,904

35
980
2
0.68
1,960
1
69
980
1:1
1,960

36.
1,036
56
18.92
58,016
49.88
1,036
1:1
58,016

TOTAL
296
100.00
116,312
100.00

116,312

Unsubscribed portion of 33,688 Equity Shares spilled over to QIB.

D. Allotment to QIBs

Allotment to QIBs, who have Bid at the Offer Price of Rs. 531 per
Equity Share or above, has been done on a proportionate basis in consultation with the
NSE. This category has been subscribed to the extent of 8,03922 times of QIB Portion. As
per the SEBI Regulations. Mutual Funds were Allotted 5% of the Equity Shares of QIB
Portion available i.e. 577,493 Equity Shares and other QIBs and unsatisfied demand of
Mutual Funds were Allotted the remaining available Equity Shares i.e. 10,972,361 Equity
Shares on a proportionate basis, The total number of Equity Shares Allotted in the QIB
Portion is 11,549,854 Equity Shares (including spilled over from other categories), which
were allotted to 77 successful QIB Bidders. The category-wise details of the Basis of
Allotment are as under

Category
Fls/Banks
Flls/FPIs
IC
MFs
OTHs
Total

QIB
1,56,752
59,95,576
3,71,356
34,65,650
15,60,520
1,15,49,854

Includes spilled over of 4,459,086 Equity Shares from Retail. NIB &
Employee category.

E. Allotment to Anchor Investors

The Company and tho Soiling Shareholders, in consultation with the
BRLMs, have allocated 10,661,418 Equity Shares to 32 Anchor Investors (through 41
Applications) at the Anchor Investor Offer Price of Rs. 531 per Equity Share in accordance
with the SEBI Regulations. This represents 60% of the QIB Portion.

E. Allotment to Anchor Investors

The Company and tho Soiling Shareholders, in consultation with the
BRLMs, have allocated 10,661,418 Equity Shares to 32 Anchor Investors (through 41
Applications) at the Anchor Investor Offer Price of Rs 531 per Equity Share In accordance
with the SEBI Regulations. This represents 60% of the QlB Portion,

Category
MFs
ICs
AIFs
FPI/Flls
Total

Anchor
3,564,316
753,312
375,060
5,968,730
10,661,418

The IPO Committee of our Company on September 8, 2021 has taken on
record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange,
being NSE and has allotted the Equity Shares to various successful Bidders, The Allotment
Advice-cum- Intimations and/ or notices will be dispatched to the address of the investors
as registered with the depositories. Further, the instructions to the Self Certified
Syndicate Banks for unblocking of funds, transfer to Public Offer Account have been issued
on September 8,2021 and payment to non-Syndicate brokers have been issued on September 9,
2021. In case the same is not received within ten days, investors may contact the
Registrar to the Offer at the address given below. The Equity Shares Allotted to the
successful Allottees have been uploaded on September 9, 2021 for credit into the
respective beneficiary accounts subject to validation of the account details with the
depositories concerned The Company has filed the Listing application with NSE and BSE on
September 9, 2021. The Company has received listing and trading approval from NSE and BSE
and the trading will commence on September 14, 2021.

All capitalised terms used and not specifically defined herein shall
have the same meaning as ascribed to them in the Prospectus.

INVESTORS PLEASE NOTE

The details of the allotment made will be hosted on the website of the
Registrar to the Offer, KFin Technologies Private Limited at www.kfintech.com

All future correspondence in this regard may kindly be addressed to the
Registrar to the Offer quoting full name of the first/ sole Bidder, Bid cum Application
Form number. Bidder DP ID, Client ID, PAN, date of submission of Bid cum Application Form,
address of the Bidder, number of Equity Shares applied for, the name and address of the
Designated Intermediary where the Bid cum Application Form was submitted by the Bidder and
a copy of the Acknowledgment Slip received from the Designated Intermediary at the address
given below.

KFin
Technologies Private Limited

Selenium, Tower
B, Plot No- 31 and 32, Financial District. Nanakramguda. Serilingampalty,

Hyderabad,
Rangareedi - 500 032, Telangana, India

Tel +91
40 6716 2222/1800 309 4001; E-mail vijaya.ipo@kfmtech.com;

Investor
grievance e-mail: einward.ris@kfintech.com;
Website: www.kfintech.com

Contact
Person: M Murali Krishna; SEBI Registration No.: INR000000221

For Vijaya Diagnostic
Centre Limited

On behalf of the Board of
Directors

Place: Hyderabad
Sd/-

Date: September 13, 2021
Company Secretary and Compliance Officer

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF
EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF
VIJAYA DIAGNOSTIC CENTRE LIMITED.

Vijaya Diagnostic Centre Limited is proposing, subject to applicable
statutory and regulatory requirements, receipt of requisite approvals market conditions
and other considerations, to make an initial public offering of its Equity Shares and has
filed the Prospectus with RoC. The Prospectus shall be available on the website of SEBI at
www.sebi.gov.in, websites of the Stock Exchanges i e.
BSE and NSE at www.bseindia.com and www.nseindia.com, respectively, and is available on the
websites of the BRLMs i.e. ICICI Securities Limited. Edelweiss Financial Services Limited
and Kotak Mahindra Capital Company Limited at www.icicisecurities.com,
www.edelweissfin.com and https://investmentbank.kotak.com respectively.
Bidders should note that investment in equity shares involves a high degree of risk and
for details relating to the same, please see the section enabled "Risk Factors"
on page 21 of the Prospectus,

The Equity Shares have not been and will not be registered under the
U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or
any other applicable law of the United States and. unless so registered, may not be
offered or sold within the United Slates, except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the U.S. Securities Act and
applicable state securities laws. Accordingly, the Equity Shares are being offered and
sold (i) within the United States only to persons reasonably believed to be
"qualified institutional buyers" (as defined in Rule 144A under the U.S.
Securities Act) under Section 4(a) of the U.S. Securities Act. And (ii) outside the United
States in offshore transactions as defined in and in compliance with Regulation S under
the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and
sales are made. There will be no public offering of Equity Shares in the United States}

Vijaya Diagnostic IPO Basis of Allotment FAQs

The IPO allocation is based on the subscription level and the investor category.

Refer to IPO allotment rules and methods for more details.

See the basis of allotment document above to know how the shares are allocated in Vijaya Diagnostic IPO .

The Vijaya Diagnostic IPO basis of allotment (published above) tells you how shares are allocated to you in Vijaya Diagnostic IPO and category wise demand of IPO share.

Visit the Vijaya Diagnostic IPO allotment status page to check the number of shares allocated to your application.

In Vijaya Diagnostic IPO allotment process, the registrar separates valid and invalid applications. The invalid applications with technical errors are rejected and only valid applications at or above the cut-off price are considered for allotment.

For more information, please refer to IPO Allotment Process and Basis of Allotment.

Check the Vijaya Diagnostic IPO basis of allotment document to know how the shares are allocated in Vijaya Diagnostic IPO.

Vijaya Diagnostic IPO Basis of Allotment

Vijaya Diagnostic IPO Basis of Allotment FAQs

How shares are allotted in Vijaya Diagnostic IPO?

What is Vijaya Diagnostic IPO basis of allotment status?

What is Vijaya Diagnostic IPO allotment process?

Read more about Vijaya Diagnostic IPO